Trexquant Investment LP Silk Road Medical Inc Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$16.95 - $27.04 $3 Million - $4.78 Million	176,724 Added 1479.6%	188,668 $5.1 Million
Q1 2024 May 14, 2024	BUY	$11.38 - $19.03 $135,922 - $227,294	11,944 New	11,944 $218,000
Q3 2023 Nov 13, 2023	SELL	$14.99 - $32.65 $296,607 - $646,045	-19,787 Reduced 57.1%	14,865 $222,000
Q2 2023 Aug 11, 2023	SELL	$29.76 - $46.14 $1.09 Million - $1.69 Million	-36,535 Reduced 51.32%	34,652 $1.13 Million
Q1 2023 May 15, 2023	BUY	$38.09 - $57.79 $2.07 Million - $3.15 Million	54,438 Added 325.02%	71,187 $2.79 Million
Q4 2022 Feb 13, 2023	BUY	$40.54 - $56.2 $679,004 - $941,293	16,749 New	16,749 $885,000
Q3 2021 Nov 12, 2021	SELL	$44.0 - $65.8 $247,940 - $370,783	-5,635 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$44.66 - $63.06 $32,825 - $46,349	-735 Reduced 11.54%	5,635 $270,000
Q1 2021 May 13, 2021	BUY	$46.31 - $62.7 $294,994 - $399,399	6,370 New	6,370 $323,000
Q3 2020 Nov 06, 2020	SELL	$42.19 - $69.61 $304,147 - $501,818	-7,209 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$27.55 - $43.28 $198,607 - $312,005	7,209 New	7,209 $302,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.